{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "33014057", "DateRevised": {"Year": "2024", "Month": "08", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "09", "Day": "17"}], "Language": ["eng"], "ELocationID": ["8659802", "10.1155/2020/8659802"], "Journal": {"ISSN": "1687-8450", "JournalIssue": {"Volume": "2020", "PubDate": {"Year": "2020"}}, "Title": "Journal of oncology", "ISOAbbreviation": "J Oncol"}, "ArticleTitle": "Minocycline in Treating Glioblastoma Multiforme: Far beyond a Conventional Antibiotic.", "Pagination": {"StartPage": "8659802", "MedlinePgn": "8659802"}, "Abstract": {"AbstractText": ["One of the most lethal forms of CNS pathologies is glioblastoma multiforme (GBM) that represents high invasiveness, uncontrolled proliferation, and angiogenic features. Its invasiveness is responsible for the high recurrence even after maximal surgical interventions. Minocycline is a semisynthetic analog of tetracyclines with potential anti-inflammatory and anticancer effects, distinct from its antimicrobial activity. In this review, we highlight the importance and the cytotoxic mechanisms of minocycline on GBM pathophysiology. Considering the role of certain enzymes in autophagy, apoptosis, tumor cell invasion, and metastatic ability, the possible use of tetracyclines for cancer therapy should be investigated, especially GBM. The present study is, therefore, going to cover the main topics in minocycline pharmacology to date, encouraging its consideration as a new treatment approach for cancer and GBM."], "CopyrightInformation": "Copyright \u00a9 2020 Amir R. Afshari et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology and Pharmacology, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Afshari", "ForeName": "Amir R", "Initials": "AR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology and Pharmacology, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran."}, {"Identifier": [], "Affiliation": "Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Mollazadeh", "ForeName": "Hamid", "Initials": "H"}, {"Identifier": ["0000-0002-8656-1444"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Halal Research Center of IRI, FDA, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Sahebkar", "ForeName": "Amirhossein", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Egypt", "MedlineTA": "J Oncol", "NlmUniqueID": "101496537", "ISSNLinking": "1687-8450"}, "CoiStatement": "The authors declare that there are no conflicts of interest regarding the publication of this paper."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Blaskovich M. A., Elliott A. G., Kavanagh A. M., Ramu S., Cooper M. A. In vitro antimicrobial activity of acne drugs against skin-associated bacteria. Scientific Reports. 2019;9(1):1\u20138. doi: 10.1038/s41598-019-50746-4.", "ArticleIdList": ["10.1038/s41598-019-50746-4", "PMC6787063", "31601845"]}, {"Citation": "di Cerbo A., Pezzuto F., Guidetti G., Canello S., Corsi L. Tetracyclines: insights and updates of their use in human and animal pathology and their potential toxicity. The Open Biochemistry Journal. 2019;13(1) doi: 10.2174/1874091x01913010001.", "ArticleIdList": ["10.2174/1874091x01913010001"]}, {"Citation": "Panahi Y, Sahebkar A., Naderi Y., Barreto G. E. Neuroprotective effects of minocycline on focal cerebral ischemia injury: a systematic review. Neural Regeneration Research. 2020;15(5):773\u2013782. doi: 10.4103/1673-5374.268898.", "ArticleIdList": ["10.4103/1673-5374.268898", "PMC6990777", "31719236"]}, {"Citation": "Cankaya S., Cankaya B., Kilic U., Kilic E., Yulug B. The therapeutic role of minocycline in Parkinson\u2019s disease. Drugs in Context. 2019;8 doi: 10.7573/dic.212553.", "ArticleIdList": ["10.7573/dic.212553", "PMC6408180", "30873213"]}, {"Citation": "Noble W., Garwood C. J., Hanger D. P. Minocycline as a potential therapeutic agent in neurodegenerative disorders characterized by protein misfolding. Prion. 2009;3(2):78\u201383. doi: 10.4161/pri.3.2.8820.", "ArticleIdList": ["10.4161/pri.3.2.8820", "PMC2712603", "19458490"]}, {"Citation": "Diguet E., Gross C. E., Tison F., Bezard E. Rise and fall of minocycline in neuroprotection: need to promote publication of negative results. Experimental Neurology. 2004;189(1):1\u20134. doi: 10.1016/j.expneurol.2004.05.016.", "ArticleIdList": ["10.1016/j.expneurol.2004.05.016", "15296829"]}, {"Citation": "Giuliani F., Hader W., Wee Yong Y. Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction. Journal of Leukocyte Biology. 2005;78(1):135\u2013143. doi: 10.1189/jlb.0804477.", "ArticleIdList": ["10.1189/jlb.0804477", "15817702"]}, {"Citation": "Liu H.-Y., Yue J., Hu L.-N., et al. Chronic minocycline treatment reduces the anxiety-like behaviors induced by repeated restraint stress through modulating neuroinflammation. Brain Research Bulletin. 2018;143:19\u201326. doi: 10.1016/j.brainresbull.2018.08.015.", "ArticleIdList": ["10.1016/j.brainresbull.2018.08.015", "30149196"]}, {"Citation": "Chu L.-S., Fang S.-H., Zhou Y., et al. Minocycline inhibits 5-lipoxygenase expression and accelerates functional recovery in chronic phase of focal cerebral ischemia in rats. Life Sciences. 2010;86(5-6):170\u2013177. doi: 10.1016/j.lfs.2009.12.001.", "ArticleIdList": ["10.1016/j.lfs.2009.12.001", "20006627"]}, {"Citation": "Song Y., Wei E.-Q., Zhang W.-P., et al. Minocycline protects PC12 cells against NMDA-induced injury via inhibiting 5-lipoxygenase activation. Brain Research. 2006;1085(1):57\u201367. doi: 10.1016/j.brainres.2006.02.042.", "ArticleIdList": ["10.1016/j.brainres.2006.02.042", "16574083"]}, {"Citation": "Sadowski T., Steinmeyer J. Minocycline inhibits the production of inducible nitric oxide synthase in articular chondrocytes. The Journal of Rheumatology. 2001;28(2):336\u2013340.", "ArticleIdList": ["11246672"]}, {"Citation": "Higashi Y., Mummidi S., Sukhanov S., et al. Minocycline inhibits PDGF-BB-induced human aortic smooth muscle cell proliferation and migration by reversing miR-221- and -222-mediated RECK suppression. Cellular Signalling. 2019;57:10\u201320. doi: 10.1016/j.cellsig.2019.01.014.", "ArticleIdList": ["10.1016/j.cellsig.2019.01.014", "PMC6732797", "30716386"]}, {"Citation": "Faheem H., Mansour A., Elkordy A., et al. Neuroprotective effects of minocycline and progesterone on white matter injury after focal cerebral ischemia. Journal of Clinical Neuroscience. 2019;64:206\u2013213. doi: 10.1016/j.jocn.2019.04.012.", "ArticleIdList": ["10.1016/j.jocn.2019.04.012", "31023573"]}, {"Citation": "Song H., Fares M., Maguire K. R., Sid\u00e9n \u00c5., Pot\u00e1cov\u00e1 Z. Cytotoxic effects of tetracycline analogues (doxycycline, minocycline and COL-3) in acute myeloid leukemia HL-60 cells. PLoS One. 2014;9(12) doi: 10.1371/journal.pone.0114457.", "ArticleIdList": ["10.1371/journal.pone.0114457", "PMC4266609", "25502932"]}, {"Citation": "Huang T.-Y., Chu H.-C., Lin Y.-L., et al. Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases. Toxicology and Applied Pharmacology. 2009;237(1):69\u201382. doi: 10.1016/j.taap.2009.02.026.", "ArticleIdList": ["10.1016/j.taap.2009.02.026", "19285099"]}, {"Citation": "Ossola B., Lantto T. A., Puttonen K. A., Tuominen R. K., Raasmaja A., M\u00e4nnist\u00f6 P. T. Minocycline protects SH-SY5Y cells from 6-hydroxydopamine by inhibiting both caspase-dependent and -independent programmed cell death. Journal of Neuroscience Research. 2012;90(3):682\u2013690. doi: 10.1002/jnr.22791.", "ArticleIdList": ["10.1002/jnr.22791", "22108958"]}, {"Citation": "Sancho M., Herrera A. E., Gortat A., et al. Minocycline inhibits cell death and decreases mutant Huntingtin aggregation by targeting Apaf-1. Human Molecular Genetics. 2011;20(18):3545\u20133553. doi: 10.1093/hmg/ddr271.", "ArticleIdList": ["10.1093/hmg/ddr271", "21659333"]}, {"Citation": "Hosseinzadeh H., Mollazadeh H., Afshari A. R. Review on the potential therapeutic roles of nigella sativa in the treatment of patients with cancer: involvement of apoptosis:-black cumin and cancer. 2020;20(3):158\u2013172. doi: 10.3831/kpi.2017.20.019.", "ArticleIdList": ["10.3831/kpi.2017.20.019", "PMC5633668", "30087792"]}, {"Citation": "Carneiro B. A., El-Deiry W. S. Targeting apoptosis in cancer therapy. Nature Reviews Clinical Oncology. 2020;17(7):395\u2013417. doi: 10.1038/s41571-020-0341-y.", "ArticleIdList": ["10.1038/s41571-020-0341-y", "PMC8211386", "32203277"]}, {"Citation": "Tavana E., Mollazadeh H., Mohtashami E., et al. Quercetin: a promising phytochemical for the treatment of glioblastoma multiforme. BioFactors. 2020;46(3):356\u2013366. doi: 10.1002/biof.1605.", "ArticleIdList": ["10.1002/biof.1605", "31880372"]}, {"Citation": "Afshari A. R., Mollazadeh H., Mohtashami E., et al. Protective role of natural products in glioblastoma multiforme: a focus on nitric oxide pathway. Current Medicinal Chemistry. 2020;27 doi: 10.2174/0929867327666200130104757.", "ArticleIdList": ["10.2174/0929867327666200130104757", "32000638"]}, {"Citation": "Afshari A. R., Jalili-Nik M., Soukhtanloo M., et al. Auraptene-induced cytotoxicity mechanisms in human malignant glioblastoma (U87) cells: role of reactive oxygen species (ROS) EXCLI Journal. 2019;18:576\u2013590.", "ArticleIdList": ["PMC6785765", "31611741"]}, {"Citation": "Afshari A. R., Roshan M. K., Soukhtanloo M., et al. Cytotoxic effects of auraptene against a human malignant glioblastoma cell line. Avicenna Journal of Phytomedicine. 2019;9(4):p. 334.", "ArticleIdList": ["PMC6612248", "31309072"]}, {"Citation": "Jalili-Nik M., Sabri H., Zamiri E., et al. Cytotoxic effects of ferula Latisecta on human glioma U87 cells. Drug Research. 2019;69(12):665\u2013670. doi: 10.1055/a-0986-6543.", "ArticleIdList": ["10.1055/a-0986-6543", "31499542"]}, {"Citation": "Tavana E., Mollazadeh H., Mohtashami E., et al. Quercetin: a promising phytochemical for the treatment of glioblastoma multiforme. BioFactors. 2020;46(3):356\u2013366. doi: 10.1002/biof.1605.", "ArticleIdList": ["10.1002/biof.1605", "31880372"]}, {"Citation": "Conlon G. A., Murray G. I. Recent advances in understanding the roles of matrix metalloproteinases in tumour invasion and metastasis. The Journal of Pathology. 2019;247(5):629\u2013640. doi: 10.1002/path.5225.", "ArticleIdList": ["10.1002/path.5225", "30582157"]}, {"Citation": "Roshan M. K., Soltani A., Soleimani A., Kahkhaie K. R., Afshari A. R., Soukhtanloo M. J. B. Role of AKT and mTOR signaling pathways in the induction of epithelial-mesenchymal transition (EMT) process. Biochime. 2019;165:229\u2013234. doi: 10.1016/j.biochi.2019.08.003.", "ArticleIdList": ["10.1016/j.biochi.2019.08.003", "31401189"]}, {"Citation": "Modheji M., Olapour S., Khodayar M. J., Jalili A., Yaghooti H. Minocycline is more potent than tetracycline and doxycycline in inhibiting MMP-9 in vitro. Jundishapur Journal of Natural Pharmaceutical Products. 2016;11(2):p. e27377. doi: 10.17795/jjnpp-27377.", "ArticleIdList": ["10.17795/jjnpp-27377"]}, {"Citation": "Masumori N., Tsukamoto T., Miyao N., Kumamoto Y., Saiki I., Yoneda J. Inhibitory effect of minocycline on in vitro invasion and experimental metastasis of mouse renal adenocarcinoma. Journal of Urology. 1994;151(5):1400\u20131404. doi: 10.1016/s0022-5347(17)35268-0.", "ArticleIdList": ["10.1016/s0022-5347(17)35268-0", "8158795"]}, {"Citation": "Saikali Z., Singh G. Doxycycline and other tetracyclines in the treatment of bone metastasis. Anti-Cancer Drugs. 2003;14(10):773\u2013778. doi: 10.1097/00001813-200311000-00001.", "ArticleIdList": ["10.1097/00001813-200311000-00001", "14597870"]}, {"Citation": "Niu G., Liao Z., Cai L., Wei R., Sun L. The combined effects of celecoxib and minocycline hydrochloride on inhibiting the osseous metastasis of breast cancer in nude mice. Cancer Biotherapy and Radiopharmaceuticals. 2008;23(4):469\u2013476. doi: 10.1089/cbr.2008.0475.", "ArticleIdList": ["10.1089/cbr.2008.0475", "18771351"]}, {"Citation": "Li K., Tay F. R., Yung Yiu C. K. The past, present and future perspectives of matrix metalloproteinase inhibitors. Pharmacology & Therapeutics. 2020;207 doi: 10.1016/j.pharmthera.2019.107465.107465", "ArticleIdList": ["10.1016/j.pharmthera.2019.107465", "31863819"]}, {"Citation": "Ataie-Kachoie P., Morris D. L., Pourgholami M. H. Minocycline suppresses interleukine-6, its receptor system and signaling pathways and impairs migration, invasion and adhesion capacity of ovarian cancer cells: in vitro and in vivo studies. PLoS One. 2013;8(4) doi: 10.1371/journal.pone.0060817.e60817", "ArticleIdList": ["10.1371/journal.pone.0060817", "PMC3620477", "23593315"]}, {"Citation": "Khongthong P., Roseweir A. K., Edwards J. The NF-KB pathway and endocrine therapy resistance in breast cancer. Endocrine-Related Cancer. 2019;26(6):R369\u2013R380. doi: 10.1530/erc-19-0087.", "ArticleIdList": ["10.1530/erc-19-0087", "32013374"]}, {"Citation": "Weiler J., Dittmar T. Minocycline impairs TNF-\u03b1-induced cell fusion of M13SV1-Cre cells with MDA-MB-435-pFDR1 cells by suppressing NF-\u03baB transcriptional activity and its induction of target-gene expression of fusion-relevant factors. Cell Communication and Signaling. 2019;17(1):p. 71. doi: 10.1186/s12964-019-0384-9.", "ArticleIdList": ["10.1186/s12964-019-0384-9", "PMC6604204", "31266502"]}, {"Citation": "Sharma R., Kim S.-Y., Sharma A., et al. Activated microglia targeting dendrimer-minocycline conjugate as therapeutics for neuroinflammation. Bioconjugate Chemistry. 2017;28(11):2874\u20132886. doi: 10.1021/acs.bioconjchem.7b00569.", "ArticleIdList": ["10.1021/acs.bioconjchem.7b00569", "PMC6023550", "29028353"]}, {"Citation": "Kloppenburg M., Brinkman B. M., de Rooij-Dijk H. H., et al. The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes. Antimicrobial Agents and Chemotherapy. 1996;40(4):934\u2013940. doi: 10.1128/aac.40.4.934.", "ArticleIdList": ["10.1128/aac.40.4.934", "PMC163234", "8849255"]}, {"Citation": "Pourgholami M. H., Ataie-Kachoie P., Badar S., Morris D. L. Minocycline inhibits malignant ascites of ovarian cancer through targeting multiple signaling pathways. Gynecologic Oncology. 2013;129(1):113\u2013119. doi: 10.1016/j.ygyno.2012.12.031.", "ArticleIdList": ["10.1016/j.ygyno.2012.12.031", "23274564"]}, {"Citation": "Nikodemova M., Duncan I. D., Watters J. J. Minocycline exerts inhibitory effects on multiple mitogen-activated protein kinases and I\u03baB\u03b1 degradation in a stimulus-specific manner in microglia. Journal of Neurochemistry. 2006;96(2):314\u2013323. doi: 10.1111/j.1471-4159.2005.03520.x.", "ArticleIdList": ["10.1111/j.1471-4159.2005.03520.x", "16336636"]}, {"Citation": "Ataie-Kachoie P., Badar S., Morris D. L., Pourgholami M. H. Minocycline targets NF-\u043aB pathway through suppression of TGF-\u03b21-TAK1-I\u043aB kinase axis in ovarian cancer: in vitro and in vivo studies. Molecular Cancer Research. 2013;11(10):1279\u20131291. doi: 10.1158/1541-7786.MCR-13-0239.", "ArticleIdList": ["10.1158/1541-7786.MCR-13-0239", "23858099"]}, {"Citation": "Ataie-Kachoie P., Badar S., Morris D. L., Pourgholami M. H. Minocycline targets the NF-\u03baB nexus through suppression of TGF-\u03b21-TAK1-I\u03baB signaling in ovarian cancer. Molecular Cancer Research. 2013;11(10):1279\u20131291. doi: 10.1158/1541-7786.mcr-13-0239.", "ArticleIdList": ["10.1158/1541-7786.mcr-13-0239", "23858099"]}, {"Citation": "Jalili-Nik M., Sadeghi M. M., Mohtashami E., et al. Zerumbone promotes cytotoxicity in human malignant glioblastoma cells through Reactive Oxygen Species (ROS) generation. Oxidative Medicine and Cellular Longevity. 2020;2020 doi: 10.1155/2020/3237983.3237983", "ArticleIdList": ["10.1155/2020/3237983", "PMC7225859", "32454937"]}, {"Citation": "Sahab-Negah S., Ariakia F., Jalili-Nik M., et al. Curcumin loaded in niosomal nanoparticles improved the anti-tumor effects of free curcumin on glioblastoma stem-like cells: an in vitro study. Molecular Neurobiology. 2020;57:3391\u20133411.", "ArticleIdList": ["PMC7340659", "32430842"]}, {"Citation": "Soukhtanloo M., Mohtashami E., Maghrouni A., et al. Natural products as promising targets in glioblastoma multiforme: a focus on NF-\u03bab signaling pathway. 2020;72(2):285\u2013295. doi: 10.1007/s43440-020-00081-7.", "ArticleIdList": ["10.1007/s43440-020-00081-7", "32152926"]}, {"Citation": "Quintero-Fabi\u00e1n S., Arreola R., Becerril-Villanueva E., et al. Role of matrix metalloproteinases in angiogenesis and cancer. Frontiers in Oncology. 2019;9:p. 1370. doi: 10.3389/fonc.2019.01370.", "ArticleIdList": ["10.3389/fonc.2019.01370", "PMC6915110", "31921634"]}, {"Citation": "Aslan C., Maralbashi S., Salari F., et al. Tumor\u2010derived exosomes: implication in angiogenesis and antiangiogenesis cancer therapy. Journal of Cellular Physiology. 2019;234(10):16885\u201316903. doi: 10.1002/jcp.28374.", "ArticleIdList": ["10.1002/jcp.28374", "30793767"]}, {"Citation": "Qin S., Li A., Yi M., Yu S., Zhang M., Wu K. Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy. Journal of Hematology & Oncology. 2019;12(1):p. 27. doi: 10.1186/s13045-019-0718-5.", "ArticleIdList": ["10.1186/s13045-019-0718-5", "PMC6417086", "30866992"]}, {"Citation": "Li C.-H., Liao P.-L., Yang Y.-T., et al. Minocycline accelerates hypoxia-inducible factor-1 alpha degradation and inhibits hypoxia-induced neovasculogenesis through prolyl hydroxylase, von Hippel\u2013Lindau-dependent pathway. Archives of Toxicology. 2014;88(3):659\u2013671.", "ArticleIdList": ["24292262"]}, {"Citation": "Huang H.-C., Liu J., Baglo Y., et al. Mechanism-informed repurposing of minocycline overcomes resistance to topoisomerase inhibition for peritoneal carcinomatosis. Molecular Cancer Therapeutics. 2018;17(2):508\u2013520. doi: 10.1158/1535-7163.mct-17-0568.", "ArticleIdList": ["10.1158/1535-7163.mct-17-0568", "PMC5805648", "29167313"]}, {"Citation": "Yao J. S., Shen F., Young W. L., Yang G.-Y. Comparison of doxycycline and minocycline in the inhibition of VEGF-induced smooth muscle cell migration. Neurochemistry International. 2007;50(3):524\u2013530. doi: 10.1016/j.neuint.2006.10.008.", "ArticleIdList": ["10.1016/j.neuint.2006.10.008", "PMC1876824", "17145119"]}, {"Citation": "Yao J. S., Chen Y., Zhai W., Xu K., Young W. L., Yang G.-Y. Minocycline exerts multiple inhibitory effects on vascular endothelial growth factor-induced smooth muscle cell migration. Circulation Research. 2004;95(4):364\u2013371. doi: 10.1161/01.res.0000138581.04174.2f.", "ArticleIdList": ["10.1161/01.res.0000138581.04174.2f", "15256478"]}, {"Citation": "Gilbertson-Beadling S., Powers E. A., Stamp-Cole M., et al. The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism. Cancer Chemotherapy and Pharmacology. 1995;36(5):418\u2013424. doi: 10.1007/bf00686191.", "ArticleIdList": ["10.1007/bf00686191", "7543375"]}, {"Citation": "Maxwell P. H., Ratcliffe P. J. Seminars in Cell & Developmental Biology. Elsevier; 2002. Oxygen sensors and angiogenesis.", "ArticleIdList": ["11969369"]}, {"Citation": "Hirota K., Semenza G. L. Regulation of angiogenesis by hypoxia-inducible factor 1. Critical Reviews in Oncology/Hematology. 2006;59(1):15\u201326. doi: 10.1016/j.critrevonc.2005.12.003.", "ArticleIdList": ["10.1016/j.critrevonc.2005.12.003", "16716598"]}, {"Citation": "Jung H.-J., Seo I., Jha B. K., Suh S.-I., Suh M.-H., Baek W.-K. Minocycline inhibits angiogenesis in vitro through the translational suppression of HIF-1\u03b1. Archives of Biochemistry and Biophysics. 2014;545:74\u201382. doi: 10.1016/j.abb.2013.12.023.", "ArticleIdList": ["10.1016/j.abb.2013.12.023", "24412777"]}, {"Citation": "Wang P., Guan D., Zhang X. P., Liu F., Wang W. Modeling the regulation of p53 activation by HIF\u20101 upon hypoxia. FEBS Letters. 2019;593(18):2596\u20132611. doi: 10.1002/1873-3468.13525.", "ArticleIdList": ["10.1002/1873-3468.13525", "31282018"]}, {"Citation": "Tsubaki M., Takeda T., Tomonari Y., et al. Overexpression of HIF-1\u03b1 contributes to melphalan resistance in multiple myeloma cells by activation of ERK1/2, Akt, and NF-\u03baB. Laboratory Investigation. 2019;99(1):72\u201384. doi: 10.1038/s41374-018-0114-8.", "ArticleIdList": ["10.1038/s41374-018-0114-8", "30353128"]}, {"Citation": "Ai Z., Lu Y., Qiu S., Fan Z. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism. Cancer Letters. 2016;373(1):36\u201344. doi: 10.1016/j.canlet.2016.01.009.", "ArticleIdList": ["10.1016/j.canlet.2016.01.009", "PMC4769873", "26801746"]}, {"Citation": "Horiuchi A., Imai T., Shimizu M., et al. Hypoxia-induced changes in the expression of VEGF, HIF-1 alpha and cell cycle-related molecules in ovarian cancer cells. Anticancer Research. 2002;22(5):2697\u20132702.", "ArticleIdList": ["12529984"]}, {"Citation": "Ataie-Kachoie P., Pourgholami M. H., Bahrami -B. F., Badar S., Morris D. L. Minocycline attenuates hypoxia-inducible factor-1\u03b1 expression correlated with modulation of p53 and AKT/mTOR/p70S6K/4E-BP1 pathway in ovarian cancer: in vitro and in vivo studies. American Journal of Cancer Research. 2015;5(2):p. 575.", "ArticleIdList": ["PMC4396050", "25973298"]}, {"Citation": "Cao Z., Liao Q., Su M., Huang K., Jin J., Cao D. AKT and ERK dual inhibitors: the way forward? Cancer Letters. 2019;459:30\u201340. doi: 10.1016/j.canlet.2019.05.025.", "ArticleIdList": ["10.1016/j.canlet.2019.05.025", "31128213"]}, {"Citation": "Samatar A. A., Poulikakos P. I. Targeting RAS-ERK signalling in cancer: promises and challenges. Nature Reviews Drug Discovery. 2014;13(12):928\u2013942. doi: 10.1038/nrd4281.", "ArticleIdList": ["10.1038/nrd4281", "25435214"]}, {"Citation": "Ercan D., Xu C., Yanagita M., et al. Reactivation of ERK signaling causes resistance to EGFR kinase inhibitors. Cancer Discovery. 2012;2(10):934\u2013947. doi: 10.1158/2159-8290.cd-12-0103.", "ArticleIdList": ["10.1158/2159-8290.cd-12-0103", "PMC3477553", "22961667"]}, {"Citation": "Ko J.-C., Wang T.-J., Chang P.-Y., et al. Minocycline enhances mitomycin C-induced cytotoxicity through down-regulating ERK1/2-mediated Rad51 expression in human non-small cell lung cancer cells. Biochemical Pharmacology. 2015;97(3):331\u2013340. doi: 10.1016/j.bcp.2015.07.025.", "ArticleIdList": ["10.1016/j.bcp.2015.07.025", "26212550"]}, {"Citation": "Thottian A. G. F., Babu G. K., Dasappa L., et al. Evaluation of safety and efficacy of minocycline combined with tyrosine kinase inhibitors in patients of EGFR mutated metastatic lung cancer. Annals of Oncology. 2019;30(2):p. ii76. doi: 10.1093/annonc/mdz065.010.", "ArticleIdList": ["10.1093/annonc/mdz065.010"]}, {"Citation": "Warren C. F., Wong-Brown M. W., Bowden N. A. BCL-2 family isoforms in apoptosis and cancer. Cell Death & Disease. 2019;10(3):1\u201312. doi: 10.1038/s41419-019-1407-6.", "ArticleIdList": ["10.1038/s41419-019-1407-6", "PMC6384907", "30792387"]}, {"Citation": "Jan R., Chaudhry G.-e.-S. Understanding apoptosis and apoptotic pathways targeted cancer therapeutics. Advanced Pharmaceutical Bulletin. 2019;9(2):205\u2013218. doi: 10.15171/apb.2019.024.", "ArticleIdList": ["10.15171/apb.2019.024", "PMC6664112", "31380246"]}, {"Citation": "Rangel L. P., Ferretti G. D. S., Costa C. L., et al. p53 reactivation with induction of massive apoptosis-1 (PRIMA-1) inhibits amyloid aggregation of mutant p53 in cancer cells. Journal of Biological Chemistry. 2019;294(10):3670\u20133682. doi: 10.1074/jbc.ra118.004671.", "ArticleIdList": ["10.1074/jbc.ra118.004671", "PMC6416452", "30602570"]}, {"Citation": "Khan H., Reale M., Ullah H., et al. Anti-cancer effects of polyphenols via targeting p53 signaling pathway: updates and future directions. Biotechnology Advances. 2020;38 doi: 10.1016/j.biotechadv.2019.04.007.107385", "ArticleIdList": ["10.1016/j.biotechadv.2019.04.007", "31004736"]}, {"Citation": "Pourgholami M. H., Mekkawy A. H., Badar S., Morris D. L. Minocycline inhibits growth of epithelial ovarian cancer. Gynecologic Oncology. 2012;125(2):433\u2013440. doi: 10.1016/j.ygyno.2012.01.006.", "ArticleIdList": ["10.1016/j.ygyno.2012.01.006", "22252097"]}, {"Citation": "Fares M., Abedi-Valugerdi M., Hassan M., Pot\u00e1cov\u00e1 Z. DNA damage, lysosomal degradation and Bcl-xL deamidation in doxycycline- and minocycline-induced cell death in the K562 leukemic cell line. Biochemical and Biophysical Research Communications. 2015;463(3):268\u2013274. doi: 10.1016/j.bbrc.2015.05.043.", "ArticleIdList": ["10.1016/j.bbrc.2015.05.043", "26022120"]}, {"Citation": "Ruiz-Moreno C., Velez-Pardo C., Jimenez-Del-Rio M. Minocycline induces apoptosis in acute lymphoblastic leukemia Jurkat cells. Toxicology in Vitro. 2018;50:336\u2013346. doi: 10.1016/j.tiv.2018.03.012.", "ArticleIdList": ["10.1016/j.tiv.2018.03.012", "29625165"]}, {"Citation": "Liu F.-Y., Wu A.-H., Zhou S.-J., et al. Minocycline and cisplatin exert synergistic growth suppression on hepatocellular carcinoma by inducing S phase arrest and apoptosis. Oncology Reports. 2014;32(2):835\u2013844. doi: 10.3892/or.2014.3248.", "ArticleIdList": ["10.3892/or.2014.3248", "24919588"]}, {"Citation": "Mathew R., Karantza-Wadsworth V., White E. Role of autophagy in cancer. Nature Reviews Cancer. 2007;7(12):961\u2013967. doi: 10.1038/nrc2254.", "ArticleIdList": ["10.1038/nrc2254", "PMC2866167", "17972889"]}, {"Citation": "Levy J. M. M., Towers C. G., Thorburn A. Targeting autophagy in cancer. Nature Reviews Cancer. 2017;17(9):528\u2013542. doi: 10.1038/nrc.2017.53.", "ArticleIdList": ["10.1038/nrc.2017.53", "PMC5975367", "28751651"]}, {"Citation": "Kondo Y., Kanzawa T., Sawaya R., Kondo S. The role of autophagy in cancer development and response to therapy. Nature Reviews Cancer. 2005;5(9):726\u2013734. doi: 10.1038/nrc1692.", "ArticleIdList": ["10.1038/nrc1692", "16148885"]}, {"Citation": "Kondo Y., Kondo S. Autophagy and cancer therapy. Autophagy. 2006;2(2):85\u201390. doi: 10.4161/auto.2.2.2463.", "ArticleIdList": ["10.4161/auto.2.2.2463", "16874083"]}, {"Citation": "Du B., Zhang Y., Tang Y., Wang P. Minocycline attenuates ototoxicity and enhances antitumor activity of cisplatin treatment in vitro. Otolaryngology-Head and Neck Surgery. 2011;144(5):719\u2013725. doi: 10.1177/0194599810395090.", "ArticleIdList": ["10.1177/0194599810395090", "21493367"]}, {"Citation": "Lin Y., Jiang M., Chen W., Zhao T., Wei Y. Cancer and ER stress: mutual crosstalk between autophagy, oxidative stress and inflammatory response. Biomedicine & Pharmacotherapy. 2019;118 doi: 10.1016/j.biopha.2019.109249.109249", "ArticleIdList": ["10.1016/j.biopha.2019.109249", "31351428"]}, {"Citation": "Garrido-Mesa N., Camuesco D., Arribas B., et al. The intestinal anti-inflammatory effect of minocycline in experimental colitis involves both its immunomodulatory and antimicrobial properties. Pharmacological Research. 2011;63(4):308\u2013319. doi: 10.1016/j.phrs.2010.12.011.", "ArticleIdList": ["10.1016/j.phrs.2010.12.011", "21193045"]}, {"Citation": "Zhang E., Zhao X., Zhang L., et al. Minocycline promotes cardiomyocyte mitochondrial autophagy and cardiomyocyte autophagy to prevent sepsis-induced cardiac dysfunction by Akt/mTOR signaling. 2020;24(3-4):369\u2013381. doi: 10.1007/s10495-019-01521-3.", "ArticleIdList": ["10.1007/s10495-019-01521-3", "30756206"]}, {"Citation": "Deretic V., Levine B. Autophagy balances inflammation in innate immunity. Autophagy. 2018;14(2):243\u2013251. doi: 10.1080/15548627.2017.1402992.", "ArticleIdList": ["10.1080/15548627.2017.1402992", "PMC5902214", "29165043"]}, {"Citation": "Sun J., Shigemi H., Cao M., et al. Minocycline induces autophagy and inhibits cell proliferation in LPS-stimulated THP-1 cells. BioMed Research International. 2020;2020:13. doi: 10.1155/2020/5459209.5459209", "ArticleIdList": ["10.1155/2020/5459209", "PMC7387962", "32766308"]}, {"Citation": "Nozaki Y., Yamagata T., Sugiyama M., Ikoma S., Kinoshita K., Funauchi M. Anti-inflammatory effect of all-trans-retinoic acid in inflammatory arthritis. Clinical Immunology. 2006;119(3):272\u2013279. doi: 10.1016/j.clim.2005.11.012.", "ArticleIdList": ["10.1016/j.clim.2005.11.012", "16412693"]}, {"Citation": "Chen M.-C., Hsu S.-L., Lin H., Yang T.-Y. Retinoic acid and cancer treatment. BioMedicine. 2014;4(4) doi: 10.7603/s40681-014-0022-1.", "ArticleIdList": ["10.7603/s40681-014-0022-1", "PMC4265016", "25520935"]}, {"Citation": "Theodosiou M., Laudet V., Schubert M. From carrot to clinic: an overview of the retinoic acid signaling pathway. Cellular and Molecular Life Sciences. 2010;67(9):1423\u20131445. doi: 10.1007/s00018-010-0268-z.", "ArticleIdList": ["10.1007/s00018-010-0268-z", "PMC11115864", "20140749"]}, {"Citation": "Das B. C., Thapa P., Karki R., et al. Retinoic acid signaling pathways in development and diseases. Bioorganic & Medicinal Chemistry. 2014;22(2):673\u2013683. doi: 10.1016/j.bmc.2013.11.025.", "ArticleIdList": ["10.1016/j.bmc.2013.11.025", "PMC4447240", "24393720"]}, {"Citation": "Yan T.-D., Wu H., Zhang H.-P., et al. Oncogenic potential of retinoic acid receptor- in hepatocellular carcinoma. Cancer Research. 2010;70(6):2285\u20132295. doi: 10.1158/0008-5472.can-09-2968.", "ArticleIdList": ["10.1158/0008-5472.can-09-2968", "20197465"]}, {"Citation": "Purton L. E., Dworkin S., Olsen G. H., et al. RAR\u03b3 is critical for maintaining a balance between hematopoietic stem cell self-renewal and differentiation. Journal of Experimental Medicine. 2006;203(5):1283\u20131293. doi: 10.1084/jem.20052105.", "ArticleIdList": ["10.1084/jem.20052105", "PMC2121209", "16682494"]}, {"Citation": "Clarke N., Germain P., Altucci L., Gronemeyer H. Retinoids: potential in cancer prevention and therapy. Expert Reviews in Molecular Medicine. 2004;6(25):1\u201323. doi: 10.1017/s1462399404008488.", "ArticleIdList": ["10.1017/s1462399404008488", "15569396"]}, {"Citation": "Kadigamuwa C., Choksi S., Xu Q., et al. Role of retinoic acid receptor-\u03b3 in DNA damage-induced necroptosis. iScience. 2019;17:74\u201386. doi: 10.1016/j.isci.2019.06.019.", "ArticleIdList": ["10.1016/j.isci.2019.06.019", "PMC6606929", "31255985"]}, {"Citation": "Clemens V., Regen F., Le Bret N., Heuser I., Hellmann-Regen J. Anti-inflammatory effects of minocycline are mediated by retinoid signaling. BMC Neuroscience. 2018;19(1):1\u201310. doi: 10.1186/s12868-018-0460-x.", "ArticleIdList": ["10.1186/s12868-018-0460-x", "PMC6151010", "30241502"]}, {"Citation": "Regen F., Heuser I., Herzog I., Hellmann-Regen J. Striking growth-inhibitory effects of minocycline on human prostate cancer cell lines. Urology. 2014;83(2):509.e1\u2013509.e6. doi: 10.1016/j.urology.2013.10.029.", "ArticleIdList": ["10.1016/j.urology.2013.10.029", "24360070"]}, {"Citation": "Hambardzumyan D., Gutmann D. H., Kettenmann H. The role of microglia and macrophages in glioma maintenance and progression. Nature Neuroscience. 2016;19(1):20\u201327. doi: 10.1038/nn.4185.", "ArticleIdList": ["10.1038/nn.4185", "PMC4876023", "26713745"]}, {"Citation": "Chen Z., Hambardzumyan D. Immune microenvironment in glioblastoma subtypes. Frontiers in Immunology. 2018;9:p. 1004. doi: 10.3389/fimmu.2018.01004.", "ArticleIdList": ["10.3389/fimmu.2018.01004", "PMC5951930", "29867979"]}, {"Citation": "Roesch S., Rapp C., Dettling S., Herold-Mende C. When immune cells turn bad-tumor-associated microglia/macrophages in glioma. International Journal of Molecular Sciences. 2018;19(2):p. 436. doi: 10.3390/ijms19020436.", "ArticleIdList": ["10.3390/ijms19020436", "PMC5855658", "29389898"]}, {"Citation": "Annovazzi L., Mellai M., Bovio E., Mazzetti S., Pollo B., Schiffer D. Microglia immunophenotyping in gliomas. Oncology Letters. 2018;15(1):998\u20131006. doi: 10.3892/ol.2017.7386.", "ArticleIdList": ["10.3892/ol.2017.7386", "PMC5772881", "29399160"]}, {"Citation": "Saha D., Martuza R. L., Rabkin S. D. Macrophage polarization contributes to glioblastoma eradication by combination immunovirotherapy and immune checkpoint blockade. Cancer Cell. 2017;32(2):253\u2013267.e5. doi: 10.1016/j.ccell.2017.07.006.", "ArticleIdList": ["10.1016/j.ccell.2017.07.006", "PMC5568814", "28810147"]}, {"Citation": "Zhai H., Heppner F. L., Tsirka S. E. Microglia/macrophages promote glioma progression. GLIA. 2011;59(3):472\u2013485. doi: 10.1002/glia.21117.", "ArticleIdList": ["10.1002/glia.21117", "PMC3080032", "21264953"]}, {"Citation": "Abraham J., Fox P. D., Condello C., Bartolini A., Koh S. Minocycline attenuates microglia activation and blocks the long-term epileptogenic effects of early-life seizures. Neurobiology of Disease. 2012;46(2):425\u2013430. doi: 10.1016/j.nbd.2012.02.006.", "ArticleIdList": ["10.1016/j.nbd.2012.02.006", "PMC3323726", "22366182"]}, {"Citation": "Silva Bastos L. F., Pinheiro de Oliveira A. C., Magnus Schlachetzki J. C., Fiebich B. L. Minocycline reduces prostaglandin E synthase expression and 8-isoprostane formation in LPS-activated primary rat microglia. Immunopharmacology and Immunotoxicology. 2011;33(3):576\u2013580. doi: 10.3109/08923973.2010.544659.", "ArticleIdList": ["10.3109/08923973.2010.544659", "21226556"]}, {"Citation": "Tao T., Fu J., Liu Y., Li Z., Li X. Minocycline prevent microglial activation via suppression of adenosine A 2A receptor in a rat stroke ischemia/reperfusion model. Sichuan da xue xue bao Yi xue ban = Journal of Sichuan University Medical. 2017;48(2):221\u2013224.", "ArticleIdList": ["28612530"]}, {"Citation": "Sriram K., Miller D. B., O\u02bcCallaghan J. P. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha. Journal of Neurochemistry. 2006;96(3):706\u2013718. doi: 10.1111/j.1471-4159.2005.03566.x.", "ArticleIdList": ["10.1111/j.1471-4159.2005.03566.x", "16405514"]}, {"Citation": "Seabrook T. J., Jiang L., Maier M., Lemere C. A. Minocycline affects microglia activation, A\u03b2 deposition, and behavior in APP-tg mice. GLIA. 2006;53(7):776\u2013782. doi: 10.1002/glia.20338.", "ArticleIdList": ["10.1002/glia.20338", "16534778"]}, {"Citation": "Boutrid H., Reinbolt R., Knopp M., et al. Abstract OT2-05-03: does minocycline mitigate chemotherapy induced neuroinflammation? A phase ii randomized placebo controlled study. Cancer Research. 2018;78(4) doi: 10.1158/1538-7445.SABCS17-OT2-05-03.", "ArticleIdList": ["10.1158/1538-7445.SABCS17-OT2-05-03"]}, {"Citation": "Bhatt L. K., Addepalli V. Attenuation of diabetic retinopathy by enhanced inhibition of MMP-2 and MMP-9 using aspirin and minocycline in streptozotocin-diabetic rats. American Journal of Translational Research. 2010;2(2):181\u2013189.", "ArticleIdList": ["PMC2855628", "20407607"]}, {"Citation": "Grobben B., De Deyn P., Slegers H. Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell and Tissue Research. 2002;310(3):257\u2013270. doi: 10.1007/s00441-002-0651-7.", "ArticleIdList": ["10.1007/s00441-002-0651-7", "12457224"]}, {"Citation": "Markovic D. S., Vinnakota K., Van Rooijen N., et al. Minocycline reduces glioma expansion and invasion by attenuating microglial MT1-MMP expression. Brain, Behavior, and Immunity. 2011;25(4):624\u2013628. doi: 10.1016/j.bbi.2011.01.015.", "ArticleIdList": ["10.1016/j.bbi.2011.01.015", "21324352"]}, {"Citation": "Yeung Y. T., Bryce N. S., Adams S., et al. p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells. Journal of Neuro-Oncology. 2012;109(1):35\u201344. doi: 10.1007/s11060-012-0875-7.", "ArticleIdList": ["10.1007/s11060-012-0875-7", "22528800"]}, {"Citation": "Hu F., Ku M.-C., Markovic D., et al. Glioma-associated microglial MMP9 expression is upregulated by TLR2 signaling and sensitive to minocycline. International Journal of Cancer. 2014;135(11):2569\u20132578. doi: 10.1002/ijc.28908.", "ArticleIdList": ["10.1002/ijc.28908", "PMC4519695", "24752463"]}, {"Citation": "Li C., Ma L., Liu Y., et al. TLR2 promotes development and progression of human glioma via enhancing autophagy. Gene. 2019;700:52\u201359. doi: 10.1016/j.gene.2019.02.084.", "ArticleIdList": ["10.1016/j.gene.2019.02.084", "30898699"]}, {"Citation": "Liu W.-T., Lin C.-H., Hsiao M., Gean P.-W. Minocycline inhibits the growth of glioma by inducing autophagy. Autophagy. 2011;7(2):166\u2013175. doi: 10.4161/auto.7.2.14043.", "ArticleIdList": ["10.4161/auto.7.2.14043", "21079420"]}, {"Citation": "Liu W.-T., Huang C.-Y., Lu I.-C., Gean P.-W. Inhibition of glioma growth by minocycline is mediated through endoplasmic reticulum stress-induced apoptosis and autophagic cell death. Neuro-Oncology. 2013;15(9):1127\u20131141. doi: 10.1093/neuonc/not073.", "ArticleIdList": ["10.1093/neuonc/not073", "PMC3748919", "23787763"]}, {"Citation": "Desjarlais M., Pratt J., Lounis A., Mounier C., Haidara K., Annabi B. Tetracycline derivative minocycline inhibits autophagy and inflammation in concanavalin-a-activated human hepatoma cells. Gene Regulation and Systems Biology. 2014;8 doi: 10.4137/grsb.s13946.GRSB.S13946", "ArticleIdList": ["10.4137/grsb.s13946", "PMC3948715", "24634581"]}, {"Citation": "Zhang L., Huang P., Chen H., et al. The inhibitory effect of minocycline on radiation-induced neuronal apoptosis via AMPK\u03b11 signaling-mediated autophagy. Scientific Reports. 2017;7(1):1\u201316. doi: 10.1038/s41598-017-16693-8.", "ArticleIdList": ["10.1038/s41598-017-16693-8", "PMC5703722", "29180765"]}, {"Citation": "Neal T., Tang N., Reid G., Byron S., Dhruv H., Berens M. Evaluating efficacy of repurposed drugs in treatment of glioblastoma. Proceedings of the American Association for Cancer Research Annual Meeting 2019; March-April 2019; Atlanta, GA, USA."}, {"Citation": "Bow H., Hwang L. S., Schildhaus N., et al. Local delivery of angiogenesis-inhibitor minocycline combined with radiotherapy and oral temozolomide chemotherapy in 9L glioma. Journal of Neurosurgery. 2014;120(3):662\u2013669. doi: 10.3171/2013.11.jns13556.", "ArticleIdList": ["10.3171/2013.11.jns13556", "24359008"]}, {"Citation": "Cai Z.-Y., Yan Y., Chen R. Minocycline reduces astrocytic reactivation and neuroinflammation in the hippocampus of a vascular cognitive impairment rat model. Neuroscience Bulletin. 2010;26(1):28\u201336. doi: 10.1007/s12264-010-0818-2.", "ArticleIdList": ["10.1007/s12264-010-0818-2", "PMC5560381", "20101270"]}, {"Citation": "Zhu S., Davis T. N., Kung A. L. Abstract A69: activation of PI3K p110\u03b1 by minocycline leads to cell dysfunction and cell death in 9L glioma. Cancer Research. 2009;69(23):p. A69."}, {"Citation": "Mollazadeh H., Mohtashami E., Mousavi S. H., et al. Deciphering the role of glutamate signaling in glioblastoma multiforme: current therapeutic modalities and future directions. Current Pharmaceutical Design. 2020;26 doi: 10.2174/1381612826666200603132456.", "ArticleIdList": ["10.2174/1381612826666200603132456", "32493186"]}, {"Citation": "Mohtashami E., Shafaei-Bajestani N., Mollazadeh H., et al. The current state of potential therapeutic modalities for glioblastoma multiforme: a clinical review. Current Drug Metabolism. 2020;21 doi: 10.2174/1389200221666200714101038.", "ArticleIdList": ["10.2174/1389200221666200714101038", "32664839"]}, {"Citation": "Hour M. J., Liu W. T., Lu I. C., Kuo S. C., Gean P. W. Aggravated DNA damage as a basis for enhanced glioma cell killing by MJ-66 in combination with minocycline. American Journal of Cancer Research. 2014;4(5):474\u201383.", "ArticleIdList": ["PMC4163612", "25232489"]}, {"Citation": "Cohen A. L., Anker C. J., Salzman K., Jensen R. L., Shrieve D. C., Colman H. A phase 1 study of repeat radiation, minocycline, and bevacizumab in patients with recurrent glioma (RAMBO) Journal of Clinical Oncology. 2014;32(15):p. 2066. doi: 10.1200/jco.2014.32.15_suppl.2066.", "ArticleIdList": ["10.1200/jco.2014.32.15_suppl.2066"]}, {"Citation": "Cohen A., Sonty K., Jensen R., et al. ACTR-84. D-termined: a phase 1 trial in newly diagnosed high grade glioma with temozolomide, radiation, and minocycline followed by adjuvant minocycline/temozolomide. Neuro-Oncology. 2017;19(6):p. vi19. doi: 10.1093/neuonc/nox168.070.", "ArticleIdList": ["10.1093/neuonc/nox168.070", "PMC11125402", "38800698"]}, {"Citation": "Chang C.-H., Liu W.-T., Hung H.-C., et al. Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells. BMC Cancer. 2017;17(1):p. 905. doi: 10.1186/s12885-017-3924-y.", "ArticleIdList": ["10.1186/s12885-017-3924-y", "PMC5747127", "29284440"]}, {"Citation": "Frazier J. L., Wang P. P., Case D., et al. Local delivery of minocycline and systemic BCNU have synergistic activity in the treatment of intracranial glioma. Journal of Neuro-Oncology. 2003;64(3):203\u2013209. doi: 10.1023/a:1025695423097.", "ArticleIdList": ["10.1023/a:1025695423097", "14558595"]}, {"Citation": "Salacz M., Kast R., Saki N., Br\u00fcning A., Karpel-Massler G., Halatsch M.-E. Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ Regimen. OncoTargets and Therapy. 2016;9:p. 2535. doi: 10.2147/ott.s100407.", "ArticleIdList": ["10.2147/ott.s100407", "PMC4854261", "27175087"]}, {"Citation": "Yang L. P., Zhu X. A., Tso M. O. Minocycline and sulforaphane inhibited lipopolysaccharide-mediated retinal microglial activation. Molecular Vision. 2007;13:1083\u20131093.", "ArticleIdList": ["PMC2779142", "17653053"]}]}], "History": [{"Year": "2020", "Month": "4", "Day": "29"}, {"Year": "2020", "Month": "8", "Day": "5"}, {"Year": "2020", "Month": "9", "Day": "3"}, {"Year": "2020", "Month": "10", "Day": "5", "Hour": "6", "Minute": "17"}, {"Year": "2020", "Month": "10", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "10", "Day": "6", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "9", "Day": "17"}], "PublicationStatus": "epublish", "ArticleIdList": ["33014057", "PMC7519463", "10.1155/2020/8659802"]}}]}